| INTRODUC TI ON
The final report of the Penrose Inquiry into the historic transmission of HIV and hepatitis C (HCV) through blood and blood products in Scotland was published on 25th March 2015. 1 The report had one recommendation: everyone who received a blood transfusion prior to 1991 and had never been tested for HCV should be offered one.
The Prime Minister of the United Kingdom and First Minister of
Scotland apologized to the victims and their families, while some patient groups branded the report a "whitewash" and publicly burned copies. [2] [3] [4] There was considerable media coverage of the report's publication and subsequent response. Much of this coverage included the recommendation that historic blood transfusion recipients should be tested for HCV. [5] [6] [7] The Scottish Government established a Short Life Working transfusion. The total number of HCV tests was significantly higher in the week following the Penrose Report and the number mentioning transfusion was significantly higher for three weeks. There was no significant increase following the awarenessraising campaign. Women and those aged over 50 years were the most likely to have mentioned transfusion. Overall HCV positivity was 3.7% and <1% for the transfusion group. The impact of both intense media coverage and the government-funded awareness-raising campaigns in terms of HCV test uptake was modest and shortlived. Our findings highlight the challenges of case-finding for HCV and the limited impact of awareness-raising. This can be used by other countries aiming to identify those infected through historic blood transfusion. 100 000 people who had received a blood transfusion prior to 1991 in Scotland were alive and eligible for testing under the recommendation and that only 100 of these (0.1%) were estimated to be HCV infected and 30 remained undiagnosed. The SLWG considered various approaches to identify those eligible for testing: retrospective testing of blood donor specimens, interrogation of clinical records for transfusion history, notifying all general practitioner (GP) patients about pre-1991 transfusion risk, delivery of a targeted awarenessraising campaign and general population screening. The SLWG recognized the need to ensure that the response was cost-effective and proportionate to the scale of the problem and most of these options were deemed inappropriate based on their prohibitively high costs and likely low effectiveness. A targeted awareness campaign to encourage past blood transfusion recipients to come forward for testing was therefore recommended, with the understanding that the effectiveness of identifying the small number of HCV infected, undiagnosed individuals was uncertain and should be evaluated.
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The main element of this campaign was information leaflets and posters (Appendix 1). A total of 380 000 fliers and 7500 posters were distributed with three quarters sent to 966 general practices in Scotland and the remainder sent to a variety of settings including pharmacies (7%), dentists (5%) and care homes (5%). These materials sign-posted those who may have had a transfusion prior to 1991 to the NHS Inform website (www.nhsinform.scot), a support helpline, and to their GP. 8 The identification of those infected with HCV through blood transfusions prior to 1991 has been attempted in various countries worldwide. The most common approach to this has been to undertake look-back studies using records of those known to have received a blood transfusion where the HCV status of the donor was either known to be positive or unknown. [9] [10] [11] [12] [13] [14] Blood transfusion risk has also been included in general awareness-raising campaigns for HCV, including those undertaken in Scotland in recent years, alongside the other risk groups. [15] [16] [17] [18] Campaigns aimed exclusively at blood transfusion recipients have been rare. 19 Here we present results of analysis of HCV test uptake following the intense media coverage of the Penrose Report publication in 2015 and the government-funded awareness-raising campaign targeting this risk group in 2016 to examine the impact of these two different interventions on HCV test uptake and those coming forward for testing.
| ME THODS

| Data source
Data from the Scottish HCV Test database were analyzed. The methods for this surveillance system have been described previously. As 
| Statistical analysis
Trends in HCV testing across 2015/2016 were analyzed using statistical process control (SPC) to monitor changes in trends and large aberrations. SPC is commonly used in a variety of settings, including health, for quality improvement purposes by distinguishing between "common cause" or normal variations and "special cause" or unusual variations in trend data. 21 SPC has also been used to analyse routinely collected data for research. 22 The SPC output includes the mean number of tests carried out per week and upper and lower control limits. The control limits are set at three standard deviations above and below the mean and so represent 99% confidence intervals. Normal variation occurs between these limits and any values that fall outside of these limits are significant outliers at the 1% level, this allows for a greater degree of "noise" in the variation and confidence that any values outside of the limits are true outliers.
Factors, including sex, age at time of test and the Scottish Index of Multiple Deprivation (SIMD), associated with mention of transfusion at the time of HCV testing were examined using logistic regression. Multivariate analyses were undertaken and interaction between factors was also considered.
Hepatitis C antibody (anti-HCV) positivity is provided for all groups.
| RE SULTS
During the study period, 22 842 individuals (11 769 in 2015 and 11 073 in 2016) received an HCV test. Table 1 Excluding the weeks following the report publication and the awareness-raising campaigns, where the number of tests had increased, an average of two HCV tests mentioning transfusion were expected per week ( Figure 1C ). In the 7 weeks following the publication of the Penrose report, the median number of tests mentioning transfusion was 25 which represented a 13-fold increase on the expected number. In the 10 weeks following the launch of the awareness-raising campaign, the median number of tests mentioning transfusion was 10, which represents a fivefold increase. In the regression analysis, females were 3.9 times more likely to mention transfusion than males (P < 0.001) and those over 50 years of age were 4.9 times more likely than those under the age of 50 (P < 0.001). Compared with the most deprived SIMD quintile (SIMD 1), those living in quintiles 3, 4 and 5 were significantly more likely to have transfusion mentioned (AOR of 2.2, 2.7 and 2.6, respectively).
| Testing trends
| Determinants of blood transfusion related testing
Interactions between factors were considered but none were found to be significant.
| HCV positivity
Hepatitis C positivity was 3.7% for all tests, 3.5% for those with clinical information but no mention of transfusion, and <1% for the transfusion group. During the study period, there was no significant variation in HCV positivity among the three groups (all positives, all positives with no mention of transfusion or positives with mention of transfusion).
| D ISCUSS I ON
This study examined the impact on HCV testing of (a) a non-targeted media event following publication of the Penrose Inquiry Final Report, which included the recommendation that anyone who had received a blood transfusion prior to 1991 should be offered a test for HCV, and (b) a targeted awareness-raising campaign to address this recommendation.
1,8 F I G U R E 1 Trends in HCV testing per week for (A) all tests, (B) those with clinical information but no mention of transfusion and (C) those
with clinical information including transfusion. HCV, hepatitis C Media coverage has been widely demonstrated to increase awareness of, and screening for, various conditions. 23 This has the greatest impact when coverage surrounds a celebrity patient. [24] [25] [26] [27] A study of HIV testing in Scotland found that television campaigns (average increase of 46% in HIV tests over 2 months) had a greater impact on testing than the non-television campaigns (average increase of 6%).
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The short-lived increases in HIV testing observed in that study are consistent with the data presented here that show increases in HCV testing that last only 7 weeks after publicity subsided. A systematic review examining the impact of mass-media campaigns on health behaviour found that the highest likelihood of success was among one-off target behaviours, such as screening, rather than habitual or ongoing, such as changes to diet or physical activity. However, the impact of such campaigns was likely to be short-lived, which is consistent with our findings. 29 Another review of targeted HCV testing interventions found that media/information-based interventions were somewhat effective in increasing test uptake compared with no targeted testing (RR = 1.26, 95% CI 0.97-1.64). 30 However, these were less effective than practitioner-based interventions, where in-practice support was provided compared with no targeted testing (RR = 2.24, 95% CI 1.44-3.48). The most effective interventions were targeted at people who inject drugs (PWID). Risk-based screening among non-PWID risk groups poses a particular challenge.
Inability to recall past risk factors and the perception that they were not at risk of HCV are well-established barriers to treatment related to the patient, particularly in an older cohort. between the most recent HCV exposures and the screening programme, which contrasts with the interventions studied here which took place 25 years after the last exposures in 1991. 19 In 2017, a UK-wide enquiry into infected blood and blood products was announced by Prime Minister Theresa May. 33 The terms of reference of the Infected Blood Public Inquiry, chaired by Sir Brian Langstaff, cover a wide range of areas and include an aim "to ascertain the numbers of people infected (directly or indirectly) in consequence of the use of infected blood" and to examine "the nature and extent of any attempt to identify those who may have been infected and might benefit from treatment…". 34 
